These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10969686)

  • 21. Gap junction uncoupling protects the heart against ischemia.
    Saltman AE; Aksehirli TO; Valiunas V; Gaudette GR; Matsuyama N; Brink P; Krukenkamp IB
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):371-6. PubMed ID: 12167798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Warm ischemia lung protection with pinacidil: an ATP regulated potassium channel opener.
    Tang DG; Pavot DR; Mouria MM; Holwitt DM; Cohen NM
    Ann Thorac Surg; 2003 Aug; 76(2):385-9; discussion 389-90. PubMed ID: 12902070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart.
    Lawton JS; Sepic JD; Allen CT; Hsia PW; Damiano RJ
    Ann Thorac Surg; 1996 Jul; 62(1):31-8; discussion 38-9. PubMed ID: 8678673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged donor heart preservation with pinacidil: the role of mitochondria and the mitochondrial adenosine triphosphate-sensitive potassium channel.
    Yang L; Yu T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1057-63. PubMed ID: 20304147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial protection of immature rabbits with an ATP-sensitive K+ channel opener pinacidil.
    Lin R; Zhu X; Zhang Z; Kang M; Xia Q
    Chin Med J (Engl); 2001 Nov; 114(11):1184-8. PubMed ID: 11729516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart.
    McCully JD; Uematsu M; Parker RA; Levitsky S
    Ann Thorac Surg; 1998 Dec; 66(6):2037-43. PubMed ID: 9930490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts.
    Novalija E; Fujita S; Kampine JP; Stowe DF
    Anesthesiology; 1999 Sep; 91(3):701-12. PubMed ID: 10485782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of nitric oxide synthesis and ischemia/reperfusion attenuate coronary vasodilator response to pinacidil in isolated rat heart.
    Maczewski M; Beresewicz A
    J Physiol Pharmacol; 1997 Dec; 48(4):737-49. PubMed ID: 9444621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts.
    Fedorov VV; Glukhov AV; Ambrosi CM; Kostecki G; Chang R; Janks D; Schuessler RB; Moazami N; Nichols CG; Efimov IR
    J Mol Cell Cardiol; 2011 Aug; 51(2):215-25. PubMed ID: 21586291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
    Walsh RS; Tsuchida A; Daly JJ; Thornton JD; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Sep; 28(9):1337-41. PubMed ID: 7954642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both metabolic inhibition and mitochondrial K(ATP) channel opening are myoprotective and initiate a compensatory sarcolemmal outward membrane current.
    Irie H; Gao J; Gaudette GR; Cohen IS; Mathias RT; Saltman AE; Krukenkamp IB
    Circulation; 2003 Sep; 108 Suppl 1():II341-7. PubMed ID: 12970257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action potential duration and QT interval during pinacidil infusion in isolated rabbit hearts.
    Wu S; Hayashi H; Lin SF; Chen PS
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):872-8. PubMed ID: 16101630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium preconditioning, but not ischemic preconditioning, bypasses the adenosine triphosphate-dependent potassium (KATP) channel.
    Meldrum DR; Cain BS; Meng X; Cleveland JC; Shames BD; Donnahoo KK; Banerjee A; Harken AH
    J Surg Res; 1999 Jul; 85(1):77-82. PubMed ID: 10383841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
    Zhu B; Min S; Long C; Ye T
    Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adenosine-triphosphate-sensitive potassium-channel opener pinacidil is effective in blood cardioplegia.
    Lawton JS; Hsia PW; Damiano RJ
    Ann Thorac Surg; 1998 Sep; 66(3):768-73. PubMed ID: 9768928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function.
    Horimoto H; Saltman AE; Gaudette GR; Krukenkamp IB
    Ann Thorac Surg; 1999 Sep; 68(3):844-9. PubMed ID: 10509972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion.
    Jerome SN; Akimitsu T; Gute DC; Korthuis RJ
    Am J Physiol; 1995 May; 268(5 Pt 2):H2063-7. PubMed ID: 7771556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pinacidil pretreatment extends ischemia tolerance of neonatal rabbit hearts.
    Feng J; Li H; Rosenkranz ER
    J Surg Res; 2000 May; 90(2):131-7. PubMed ID: 10792953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning.
    Toyoda Y; Di Gregorio V; Parker RA; Levitsky S; McCully JD
    Circulation; 2000 Nov; 102(19 Suppl 3):III326-31. PubMed ID: 11082409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.